Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - purpura, trombocytopenisk, idiopatisk - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 och 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 och 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

glenmark arzneimittel gmbh - eltrombopagolamin - filmdragerad tablett - 75 mg - isomalt hjälpämne; mannitol hjälpämne; eltrombopagolamin 95,7 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

glenmark arzneimittel gmbh - eltrombopagolamin - filmdragerad tablett - 12,5 mg - eltrombopagolamin 15,95 mg aktiv substans; isomalt hjälpämne; mannitol hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

glenmark arzneimittel gmbh - eltrombopagolamin - filmdragerad tablett - 25 mg - isomalt hjälpämne; mannitol hjälpämne; eltrombopagolamin 31,9 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

glenmark arzneimittel gmbh - eltrombopagolamin - filmdragerad tablett - 50 mg - eltrombopagolamin 63,8 mg aktiv substans; mannitol hjälpämne; isomalt hjälpämne